Bridging communities in the field of nanomedicine

An early dialogue between nanomedicine developers and regulatory authorities are of utmost importance to anticipate quality and safety requirements for these innovative health products. In order to stimulate interactions between the various communities involved in a translation of nanomedicines to c...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Regul Toxicol Pharmacol
Glavni autori: Halamoda-Kenzaoui, Blanka, Baconnier, Simon, Bastogne, Thierry, Bazile, Didier, Boisseau, Patrick, Borchard, Gerrit, Borgos, Sven Even, Calzolai, Luigi, Cederbrant, Karin, Di Felice, Gabriella, Di Francesco, Tiziana, Dobrovolskaia, Marina A., Gaspar, Rogério, Gracia, Belén, Hackley, Vincent A., Leyens, Lada, Liptrott, Neill, Park, Margriet, Patri, Anil, Roebben, Gert, Roesslein, Matthias, Thürmer, René, Urbán, Patricia, Zuang, Valérie, Bremer-Hoffmann, Susanne
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6597901/
https://ncbi.nlm.nih.gov/pubmed/31051191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yrtph.2019.04.011
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items